Diagnostic and Therapeutic Radiopharmaceuticals.

[1]  G. Bormans,et al.  Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET. , 2022, Journal of medicinal chemistry.

[2]  Justin J. Wilson,et al.  Evaluation of the Effect of Macrocyclic Ring Size on [203Pb]Pb(II) Complex Stability in Pyridyl-Containing Chelators. , 2022, Inorganic chemistry.

[3]  Fan Wang,et al.  IgG-Binding Nanobody Capable of Prolonging Nanobody-Based Radiotracer Plasma Half-Life and Enhancing the Efficacy of Tumor-Targeted Radionuclide Therapy. , 2022, Bioconjugate chemistry.

[4]  C. Orvig,et al.  H2ampa─Versatile Chelator for [203Pb]Pb2+, [213Bi]Bi3+, and [225Ac]Ac3. , 2022, Inorganic chemistry.

[5]  B. Rogers,et al.  68Ga-Labeled Benzothiazole Derivatives for Imaging Aβ Plaques in Cerebral Amyloid Angiopathy , 2022, ACS omega.

[6]  Zuoquan Zhao,et al.  Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein. , 2022, Journal of medicinal chemistry.

[7]  Afaf R. Genady,et al.  Pretargeted PET of Osteodestructive Lesions in Dogs. , 2022, Molecular pharmaceutics.

[8]  P. Blower,et al.  Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging , 2022, Chemical reviews.

[9]  X. Shao,et al.  Copper-Mediated Radiocyanation of Unprotected Amino Acids and Peptides. , 2022, Journal of the American Chemical Society.

[10]  O. Rousseaux,et al.  Versatile Macrocyclic Platform for the Complexation of [natY/90Y]Yttrium and Lanthanide Ions , 2022, Inorganic chemistry.

[11]  R. Mach,et al.  Screening of σ2 Receptor Ligands and In Vivo Evaluation of 11C-Labeled 6,7-Dimethoxy-2-[4-(4-methoxyphenyl)butan-2-yl]-1,2,3,4-tetrahydroisoquinoline for Potential Use as a σ2 Receptor Brain PET Tracer. , 2022, Journal of medicinal chemistry.

[12]  A. Kabashin,et al.  Transforming Nuclear Medicine with Nanoradiopharmaceuticals. , 2022, ACS nano.

[13]  A. V. van Gool,et al.  Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors. , 2022, Bioconjugate chemistry.

[14]  A. Nordberg,et al.  Development of 11C-Labeled ASEM Analogues for the Detection of Neuronal Nicotinic Acetylcholine Receptors (α7-nAChR) , 2022, ACS chemical neuroscience.

[15]  B. Kuhnast,et al.  PET/Fluorescence Imaging: An Overview of the Chemical Strategies to Build Dual Imaging Tools. , 2022, Bioconjugate chemistry.

[16]  A. Linden,et al.  Photoactivatable Fluorescent Tags for Dual-Modality Positron Emission Tomography Optical Imaging. , 2022, Journal of medicinal chemistry.

[17]  Xingdang Liu,et al.  Development of Mitochondria-Targeted Small-Molecule Dyes for Myocardial PET and Fluorescence Bimodal Imaging. , 2021, Journal of medicinal chemistry.

[18]  Bo Xu,et al.  Synthesis of ArCF2X and [18F]Ar-CF3 via Cleavage of the Trifluoromethylsulfonyl Group. , 2021, Organic letters.

[19]  R. Schuit,et al.  Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain , 2021, ACS chemical neuroscience.

[20]  T. Lammers,et al.  Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics. , 2021, ACS nano.

[21]  Gregory F. Wu,et al.  In Vitro and In Vivo Investigation of S1PR1 Expression in the Central Nervous System Using [3H]CS1P1 and [11C]CS1P1. , 2021, ACS chemical neuroscience.

[22]  M. Ono,et al.  Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen. , 2021, Journal of medicinal chemistry.

[23]  T. Ritter,et al.  18F-Fluorination: Challenge and Opportunity for Organic Chemists , 2021, The Journal of organic chemistry.

[24]  Jung Young Kim,et al.  Imaging Strategy that Achieves Ultrahigh Contrast by Utilizing Differential Esterase Activity in Organs: Application in Early Detection of Pancreatic Cancer. , 2021, ACS nano.

[25]  T. Uehara,et al.  Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios , 2021, ACS omega.

[26]  E. Tajkhorshid,et al.  Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for Soluble and Insoluble Amyloid β Aggregates in Alzheimer's Disease. , 2021, Journal of the American Chemical Society.

[27]  G. V. van Dongen,et al.  State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET , 2021, Bioconjugate chemistry.

[28]  J. Nye,et al.  Synthesis, Radiolabeling, and Biological Evaluation of the trans-Stereoisomers of 1-Amino-3-(fluoro-18F)-4-fluorocyclopentane-1-carboxylic Acid as PET Imaging Agents. , 2021, ACS pharmacology & translational science.

[29]  Jinming Zhang,et al.  Synthesis, Preclinical Evaluation, and First-in-Human PET Study of Quinoline-Containing PSMA Tracers with Decreased Renal Excretion. , 2021, Journal of medicinal chemistry.

[30]  R. Bharath,et al.  Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology. , 2021, Journal of medicinal chemistry.

[31]  P. Conti,et al.  Exploring Solvent Effects in the Radiosynthesis of 18F-Labeled Thymidine Analogues toward Clinical Translation for Positron Emission Tomography Imaging. , 2020, ACS pharmacology & translational science.

[32]  L. Królicki,et al.  Radiolabeled Peptides and Antibodies in Medicine , 2020, Bioconjugate chemistry.

[33]  G. Loudos,et al.  Conjugated Photosensitizers for Imaging and PDT in Cancer Research. , 2020, Journal of medicinal chemistry.

[34]  J. Nye,et al.  Synthesis, Radiolabeling, and Biological Evaluation of the Cis Stereoisomers of 1-amino-3-(fluoro-18F)-4-fluorocyclopentane-1-carboxylic acid as PET Imaging Agents. , 2020, Journal of medicinal chemistry.

[35]  A. Gee,et al.  Imaging Biotin Trafficking In Vivo with Positron Emission Tomography , 2020, Journal of medicinal chemistry.

[36]  A. Sutherland,et al.  Recent Advances in Synthetic Methods for Radioiodination. , 2020, The Journal of organic chemistry.

[37]  Zachary T. Rosenkrans,et al.  ImmunoPET: Concept, Design, and Applications. , 2020, Chemical reviews.

[38]  W. R. Ewing,et al.  Nucleophilic (Radio)Fluorination of Redox-Active Esters via Radical-Polar Crossover Enabled by Photoredox Catalysis. , 2020, Journal of the American Chemical Society.

[39]  A. Ordonez,et al.  Radiotracer Development for Bacterial Imaging. , 2020, Journal of medicinal chemistry.

[40]  J. Passchier,et al.  18F-Trifluoromethanesulfinate Enables Direct C–H 18F-Trifluoromethylation of Native Aromatic Residues in Peptides , 2020, Journal of the American Chemical Society.

[41]  Allen F. Brooks,et al.  Evaluation of [18F]N-methyl-lansoprazole as a tau PET imaging agent in first-in-human studies. , 2020, ACS chemical neuroscience.

[42]  A. Kjær,et al.  Trans-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging , 2019, ACS nano.

[43]  Jason S. Lewis,et al.  HER2-targeted PET imaging and therapy of hyaluronan-masked HER2-overexpressing breast cancer. , 2019, Molecular pharmaceutics.

[44]  A. Bianco,et al.  Neutron Activated 153Sm Sealed in Carbon Nanocapsules for In Vivo Imaging and Tumor Radiotherapy. , 2019, ACS nano.

[45]  Apurva Pandey,et al.  A Theranostic Gallium Siderophore Ciprofloxacin Conjugate with Broad Spectrum Antibiotic Potency. , 2019, Journal of medicinal chemistry.

[46]  A. Thiel,et al.  First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases. , 2019, ACS chemical neuroscience.

[47]  F. Bénard,et al.  Bench to Bedside: Albumin Binders for Improved Cancer Radioligand Therapies. , 2019, Bioconjugate chemistry.